INSIGHTS ON ENTERPRISE SOLUTIONS

• Where Formulation Expertise Connects

  As pipelines grow more complex and timelines become more ambitious, companies increasingly rely on strong external partners to advance their drug products efficiently and with reduced risk. 

• Increasing Patient Safety: Risk Assessment For Small Volume Fluid Management

  Explore the risk factors in small-volume fluid management, learn where manual processes introduce variability, and find out how closed, pump-driven single-use systems can improve accuracy and consistency.

• Fluid Management In HPAPI Manufacturing

  Discover how closed-system approaches in HPAPI and ADC manufacturing reduce operator exposure, support Annex 1 alignment, and deliver labor savings of up to 90%.

• Safeguarding Biologic Quality And Performance

  A science‑driven roadmap, from QTPP to QbD and phase‑appropriate strategies, helps ensure biologics stability, manufacturability, and a smooth path to successful commercialization

• Enhancing Biologics Developability With Predictive In Silico Modelling

  5/19/2026

  Predictive in silico modeling accelerates biologics development by identifying stability and formulation risks early, enabling smarter candidate selection, reduced costs, and improved success rates.

• Turning Gene Therapies Into Patient Reality: Large Scale Cost-Effective AAV Production

  5/19/2026

  Understanding how upstream control, downstream efficiency, and process robustness scale together is essential for protecting supply and expanding patient access.

• Validation Challenges Facing Advanced Single-Use Technologies

  5/18/2026

  In this episode of "Better Biopharma," host Tyler Menichiello is joined by BioPlan Associates’ director of research, Katrina Cordovado, as well as Joshua Nelson, Ph.D., a senior material qualification specialist at Takeda, and Paul Priebe, a consultant and single-use expert, to continue their conversation from the Bioprocess Online Live event, "Closing The Adoption Gap For Advanced Single-Use Materials."

• Weighing Adoption Risks And SUT Characteristics

  5/18/2026

  In this segment from the Bioprocess Online Live event “Closing The Adoption Gap For Advanced Single-Use Technologies” (SUT), the panel weighs in on how to define internal risks when adopting advanced SUTs, as well as which characteristics should be considered most when evaluating these technologies.